Galenika a.d.
 | |
| Type | Public limited company |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1945 |
| Headquarters | Zemun, Belgrade, Serbia |
| Key people | Živomir Novaković (general director) |
| Products | Generic drugs, over-the-counter drugs, medical devices |
| Revenue |
 US$ 55.48 million (2012)[1] |
| Net income |
 US$ 0 (2012)[1] |
| Total assets |
US$ 282.16 million (2012)[1] |
| Total equity |
 US$ 0 (2012)[1] |
| Employees | 2,457[1] |
| Website | www.galenika.rs |
Galenika AD is a Serbian pharmaceutical company based in Zemun, Serbia, controlling one-third of the pharmaceutical market share in the country. Founded in 1945, Galenika is a major pharmaceutical drug-maker in the Balkans with exports to Europe, Africa and Asia.
Still a state-owned company, Galenika is gradually moving towards a privatized model. The Government of Serbia announced its intent to privatize Galenika sometime in 2013.[2]
As of 2006, Galenika remains a leader in research and development as the only pharmaceutical company in Serbia with an institute registered with the Ministry of Science and Environmental Protection.[3]
According to its most recent annual financial report submitted to Serbian Business Registers Agency (SBRA), the company has 2,457 employees and it posted an annual loss of RSD 5,605,302,000 (approximately US$ 65.18 million at the time) for the calendar year of 2012.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "Основни подаци из годишњег финансијског извештаја за обвезника ревизије за 2012. годину". Agencija za privredne registre Srbije. Retrieved 2 August 2013.
- ↑ "Serbia to Start Sale of Galenika Drugmaker in Early 2013". Bloomberg. 13 December 2012. Retrieved 9 April 2013.
- ↑ Doing Business with Serbia By Marat Terterov, Consultant Editor, Marat Terterov, Inc NetLibrary; Published by GMB Publishing Ltd, 2006; ISBN 1-905050-68-2, ISBN 978-1-905050-68-0.